MSD (United Kingdom)

MSD UK (known as Merck & Co., Inc. in the United States) is the British subsidiary of the global pharmaceutical leader, developing innovative medicines and vaccines in oncology, infectious diseases, and cardiometabolic health. Key products include Keytruda (pembrolizumab) cancer immunotherapy, Gardasil HPV vaccine, Januvia for diabetes, and hospital anti-infective products.